Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Earnings Winners and Losers: JNJ, MMSI, ABT, ZBH, SNN, EW, Plus Round-Up

Executive Summary

Among the medtech companies who have released their first-quarter 2017 sales and earnings, Johnson & Johnson and Merit Medical Systems reported progress in their long-term plans to reshape their medical device businesses, while Abbott and Zimmer Biomet received some bad news in the quarter. Smith & Nephew shows signs of a turnaround, and perennial "winner" Edwards Lifesciences provided updates on some important developments in their flagship transcatheter valve business.

Advertisement

Related Content

Starts & Stops: ICS' Emblok Medtronic's Arctic Front, Abbott's Absorb, Boston Scientific's S-ICD
Despite Legal Dispute, Abbott Set To Buy Alere for $5.3bn
Deals Shaping The Medical Industry, April 2017
Earnings Winners & Losers: MMSI, STMN, WMGI, RWLK, EXAS
Earnings Winners and Losers: BSX, EW, ABT, JNJ, SYK, ZBH
To Alinity And Beyond: Abbott Dx Launches Into Its Next Phase
Abbott Becomes CRM Player Overnight By Completing St. Jude Deal
Merit Faces Subpoena Over Marketing
J&J Buys Abbott's Ophthalmics Business For $4bn-Plus
Zimmer, Biomet Sell Off Some U.S. Assets As They Finalize A $14 Bil. Merger

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT104819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel